Results 21 to 30 of about 96,770 (285)

Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial [PDF]

open access: yes, 2014
<br>Background: Loss of muscle mass and strength with ageing is a major cause for falls, disability, and morbidity in older people. Previous studies have found that angiotensin-converting enzyme inhibitors (ACEi) may improve physical function in ...
Sumukadas, Deepa   +8 more
core   +1 more source

Unrecognized recurrent perioperative angioedema requiring intubation in a patient taking long-term angiotensin-converting enzyme inhibitor therapy

open access: yesOtolaryngology Case Reports, 2022
Introduction: Angiotensin converting enzyme (ACE) inhibitors are a leading class of antihypertensives, which are a well-documented cause of angioedema related to prescription drugs. The purpose of this report is to highlight the importance of recognition
Christopher Wojcik, Brian Farrell
doaj   +1 more source

The use of angiotensin-converting enzyme inhibitors in general medicine

open access: yesSouth African Family Practice, 2012
Angiotensin-converting enzyme (ACE) inhibitors are a class of drugs commonly used in the management of hypertension, congestive heart failure, cerebrovascular disease, stable coronary heart disease and diabetes-associated nephropathy.
M.L.I. Mashitisho
doaj   +1 more source

Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2

open access: yesESC Heart Failure, 2021
Aims Concern has been raised that treatment with angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers may increase the expression of angiotensin‐converting enzyme 2 (ACE2), which acts as the entry receptor for SARS‐CoV‐2, and lead ...
Tobias Zimmermann   +8 more
doaj   +1 more source

The angiotensin-converting enzyme (ACE) gene family of Anopheles gambiae [PDF]

open access: yes, 2005
Background Members of the M2 family of peptidases, related to mammalian angiotensin converting enzyme (ACE), play important roles in regulating a number of physiological processes.
Lee, A.J.   +14 more
core   +1 more source

Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials.

open access: yesPLoS ONE, 2021
IntroductionThis meta-analysis aimed to summarize the available evidence to compare angiotensin-converting enzyme (ACE) inhibitors with angiotensin II receptor blockers (ARBs) on improving insulin sensitivity in hypertensive patients.MethodsRandomized ...
Jia Yao   +5 more
doaj   +1 more source

Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes [PDF]

open access: yes, 1994
Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Anaphylactoid reactions (AR) are the most feared complications of hemodialysis.
Verresen, Luc   +3 more
core   +1 more source

A genome-wide search replicates evidence of a quantitative trait locus for circulating angiotensisn l-converting enzyme (ACE) unlinked to the ACE gene [PDF]

open access: yes, 2008
Background: angiotensin I-converting enzyme (ACE) plays an important role in cardiovascular homeostasis. There is evidence from different ethnic groups that circulating ACE levels are influenced by a quantitative trait locus (QTL) at the ACE gene on ...
Amy Luke   +20 more
core   +1 more source

ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?

open access: yesРациональная фармакотерапия в кардиологии, 2016
New possibilities of ACE inhibitors application on the base of international trails review are presented. Traditional therapy areas of ACE inhibitors (hypertension, heart failure) are well known.
D. V. Nebieridze, A. S. Safarian
doaj   +1 more source

Secondary prevention of coronary heart disease in older patients after the national service framework: population based study [PDF]

open access: yes, 2006
Objective To examine the extent of uptake of medication for secondary prevention of coronary heart disease in older British men and women before (1998-2001) and after (2003) the implementation of the national service framework.Design Two population based,
Morris, RW   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy